Galapagos advances AbbVie-partnered CF drug; UCL forms £50M fund; Vasopharm bags €20M

Nick Paul Taylor In this week's EuroBiotech Report, the first of two correctors destined for use in Galapagos' triple-hit cystic fibrosis therapy is now in the clinic. With ...

Acorda bags PhIII Parkinson’s drug in $363M Biotie buyout

John Carroll FierceBiotech News

Cardiorentis bags $60M as PhIII nears end; J&J backs HIV player; Novartis nears Horsham sale

Nick Paul Taylor Our top stories in this week's EuroBiotech Report involve the transfer of more than $ 100 million (€92 million) from the wallets of investors to the bank ...

Kodiak bags a $34M B round for retinal R&D

Damian Garde Ophthalmology biotech Kodiak Sciences raised $ 34 million in Series B financing to speed up its pipeline of ocular therapies. FierceBiotech News

GlaxoSmithKline bags an FDA OK for its asthma drug with eyes on a respiratory turnaround

Damian Garde GlaxoSmithKline won FDA approval for an antibody designed to treat severe asthma, leading a pack of drugmakers at work on similar therapies as it seeks to bolster its respiratory ...

Grifols bags €100M for Alzheimer’s R&D; Ipsen inks $137M cancer deal; Oryzon raises €17M

Nick Paul Taylor In this week's EuroBiotech Report, Catalan biotech Grifols secured a €100 million ($ 110 million) loan from the European Investment Bank's €315 billion ...

After partnering with Big Pharmas, Incyte bags its own PD-1 drug in $795M deal

John Carroll After signing up for combo studies with all the leaders in the checkpoint inhibitor race, Incyte has found a checkpoint program for itself. FierceBiotech News

UPDATED: Allergan bags NMDA depression drugs in $560M-plus Naurex buyout

John Carroll The big news in biopharma this weekend is the unconfirmed report that Allergan is looking to sell its generics business to Teva. But Allergan execs didn't let the headlines ...

MorphoSys bags a peptide biotech for $22M

Damian Garde MorphoSys pulled the trigger on a deal for partner Lanthio Pharma, paying €20 million ($ 22 million) for the shares it didn't already own and picking up a handful ...

Astellas bags FDA approval for a new anti-infective

Damian Garde Japanese pharma giant Astellas won FDA approval for an anti-fungal treatment targeting two rare but dangerous infections, the latest drugmaker to take advantage of new ...

Novartis bags a surprise approval for the blood cancer-treating panobinostat

Damian Garde Going against the advice of its independent experts, the FDA approved Novartis' new blood cancer drug for patients with particularly deadly forms of multiple myeloma, ...

LabCorp bags Covance, diversifying into CRO biz with $6.1B buyout

John Carroll LabCorp is diversifying. The big diagnostics player has swooped in to buy the contract research organization Covance for $ 6.1 billion in cash and stock, confident that ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS